// App-Quantinova.ai

4334 : A novel linker to enable alcohol-containing payloads for the preparation of antibody-drug conjugates

Researchers

Presenter

  • Robert V. Kolakowski

Principal Investigators

  • Karl Haelsig

  • Scott Jeffrey

  • Peter Senter

Medical Centers

  • Seattle Genetics, Bothell, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Soluble Complement 5b-9

  • Apparent diffusion coefficient

Drug/Treatment

  • Adcetris

  • Phenylpropanolamine

  • Trastuzumab

  • carbamate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved